News
Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is conducting a clinical ...
The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates ...
Tier-two pharma picks show solid fundamentals, but Eli Lilly (LLY) stock stands out for its growth potential. Read here for ...
TipRanks on MSN5d
Eli Lilly (LLY) Signs $1.3 Billion Deal with Superluminal to Discover Future Drugs Using AI
Eli Lilly (LLY) has signed a $1.3 billion deal with privately held biotechnology firm Superluminal Medicines that will see ...
Eli Lilly and Company faces a pivotal period with the upcoming retirement of Anne White, a key neuroscience leader set for ...
Eli Lilly's recent performance showcases a robust recovery, driven by impressive sales of its obesity drugs, Mounjaro and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback